Stran 1 iz 231 rezultatov
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a system for preventing and curing osteoporosis and obesity, by putting a human body in an electrostatic field.
2. Related Art
In recent years, medical techniques have greatly advanced to prolong the average span
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical composition for preventing or treating osteoporosis, obesity, diabetes, or hyperlipidemia, comprising a phenyltetrazole derivative or a pharmaceutical acceptable salt thereof as an active ingredient.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical composition for preventing or treating osteoporosis, obesity, diabetes, or hyperlipidemia, comprising a phenyltetrazole derivative or a pharmaceutical acceptable salt thereof as an active ingredient.
BACKGROUND OF THE
FIELD OF THE INVENTION
The invention relates to methods and reagents for detecting an individual's risk for obesity and/or osteoporosis. More specifically, it relates to methods and reagents for detecting an individual's increased or decreased risk for obesity and/or osteoporosis by identifying the
This invention relates to estrogen agonists and antagonists and their pharmaceutical uses.
BACKGROUND OF THE INVENTION
The value of naturally occurring estrogens and synthetic compositions demonstrating "estrogenic" activity has been in their medical and therapeutic uses. A traditional listing of
FIELD OF THE INVENTION
The invention relates to a genus of nitrogen heterocycle biaryls having a carboxylate terminus. The nitrogen heterocycle biaryls are useful for treating endometriosis, osteoporosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and
BACKGROUND OF THE INVENTION
The present invention relates to a herbal medicine useful for the treatment of osteoporosis and other conditions. It may be of use in the prevention or treatment of obesity and diabetes. The medicine is derived from a number of plant materials used in traditional Chinese
FIELD OF THE INVENTION
The present invention relates to novel heterocyclic aromatic compounds which stimulate endogenous production and/or release of growth hormone, and to methods for treating obesity; improving bone density (to treat osteoporosis) and stimulating increase in muscle mass and muscle
FIELD OF THE INVENTION
The present invention relates to novel heterocyclic aromatic compounds which stimulate endogenous production and/or release of growth hormone, and to methods for treating obesity improving bone density (to treat osteoporosis) and stimulating increase in muscle mass and muscle
FIELD OF THE INVENTION
The present invention relates to novel heterocyclic aromatic compounds which stimulate endogenous production and/or release of growth hormone, and to methods for treating obesity, improving bone density (to treat osteoporosis) and stimulating increase in muscle mass and muscle
FIELD OF THE INVENTION
The present invention relates to novel heterocyclic aromatic compounds which stimulate endogenous production and/or release of growth hormone, and to methods for treating obesity, improving bone density (to treat osteoporosis) and stimulating increase in muscle mass and muscle
FIELD OF THE INVENTION
The present invention relates to novel heterocyclic aromatic compounds which stimulate endogenous production and/or release of growth hormone, and to methods for treating obesity, improving bone density (to treat osteoporosis) and stimulating increase in muscle mass and muscle
FIELD OF THE INVENTION
The present invention relates to novel heterocyclic aromatic compounds which stimulate endogenous production and/or release of growth hormone, and to methods for treating obesity, improving bone density (to treat osteoporosis) and stimulating increase in muscle mass and muscle
FIELD OF THE INVENTION
The present invention relates to novel thyroid receptor ligands and, more particularly, relates to novel cyano containing oxamic acids, and derivatives thereof, which are useful in the treatment of obesity, hyperlipidemia, thyroid disease, hypothyroidism and related disorders
FIELD OF THE INVENTION
The present invention relates to novel thyroid receptor ligands and, more particularly, relates to novel oxamic acids, and derivatives thereof, which are useful in the treatment of obesity, hyperlipidemia, glaucoma, cardiac arrhythmia, skin disorders, thyroid disease,